Results 71 to 80 of about 6,204,305 (255)

Synthesis and cytotoxicity evaluation of thiosemicarbazones and their thiazole derivatives

open access: yesBrazilian Journal of Pharmaceutical Sciences
The aims of this study were to synthesize a series of thiosemicarbazones and their thiazole derivatives, to investigate their cytotoxic activity against three human cancers and normal (Vero cells) cell lines, and to evaluate the pro-apoptotic potential ...
Saulo Feheiberg Pinto Braga   +4 more
doaj   +1 more source

Cytotoxic Activity of synthesized compounds against LS174T CRC cell lines.

open access: yes, 2017
Cytotoxic Activity of synthesized compounds against LS174T CRC cell lines.
Hanan A. Assiri (3626405)   +4 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Mitotic block and delayed lethality in HeLa epithelial cells exposed to Escherichia coli BM2-1 producing cytotoxic necrotizing factor type 1 [PDF]

open access: yes, 1996
The cytopathic effect (CPE) of Escherichia coli producing cytotoxic necrotizing factor type 1 (CNF1) was investigated by using a human epithelial cell (HeLa) model of infection with CNF1-producing E. coli BM2-1. This strain was shown to bind loosely, but
Nougayrède, Jean-Philippe   +8 more
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Cytotoxic Activity of Iraqi Cressa Cretica

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences, 2019
Cressa cretica Fam: Convolvulaceae (morning glory). These plants are native to the tropical and subtropical areas of the world. Nutritional analysis provide it to be a potential source of minerals, energy, carbohydrate, alpha-tocopherol, edible oil ...
Farah fawzi   +2 more
doaj   +1 more source

Selective Cytotoxic Activity of Prodigiosin@halloysite Nanoformulation

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Prodigiosin, a bioactive secondary metabolite produced by Serratia marcescens, is an effective proapoptotic agent against various cancer cell lines, with little or no toxicity toward normal cells.
Ivan Guryanov   +8 more
doaj   +1 more source

Synthesis and cytotoxic activity of sulfur linked mono / bis heterocycles [PDF]

open access: yes, 2018
1173-1178A variety of sulfur linked mono / bis heterocycles have been prepared and their cytotoxic activity on A549 lung adenocarcinoma cells studied. The imidazolyl and benzimidazolyl thiadiazoles (7c, 8c) display appreciable cytotoxic activity against ...
Padmavathi, Venkatapuram   +4 more
core  

Cytotoxic activity of clinical Stenotrophomonas maltophilia

open access: yes, 2015
Aims: To determine the potential virulence factors produced by culture supernatants of clinical isolates of Stenotrophomonas maltophilia. Methods and Results: Culture supernatants of clinical isolates of S.
Kota, DJ   +12 more
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy